FDA
-
-
-
-
-
-
-
Xenon reports positive phase 3 epilepsy trial results for azetukalner
-
-
-
-
-
-
-
Biotech sector Q1 earnings preview from RBC Capital Markets
-
-
-
-
-
-
-
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023
-
-
-
-
-
-
-
Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) Outlines 2022 Key Milestones
-
-
-
-
-
-
-
Xenon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
323,324 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

